Phio Pharmaceuticals

PHIO

PHIO Phio Pharmaceuticals NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    PHIO Chart
    See on advanced chart >

    About

    Phio Pharmaceuticals Corp. is a biotechnology company focused on discovering, developing and commercializing innovative therapies based on the company's proprietary, new-generation RNA interference (“RNAi”) platform. Therapeutics that use RNAi have great...
    • Highlight
      A clinical stage biotechnology company that develops therapeutics based on RNA interference
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      02/10/2014
    • Established Date
      09/08/2011
    • Full-time Employees
      8
    • Address
      257 Simarano Drive Suite 101 Marlborough Massachusetts 01752
    • Tel
      1-508-7673861
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock